Renal Cancer - Results from #4420

Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis June 19, 2018

An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma June 18, 2018

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non-clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus June 18, 2018

Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact June 15, 2018

Treatment of metastatic renal cell carcinoma in older patients: A network meta-analysis June 15, 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma June 15, 2018

Challenges in Pathologic Staging of Renal Cell Carcinoma: A Study of Interobserver Variability Among Urologic Pathologists June 14, 2018

Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment June 14, 2018

Association between preoperative hydration status and acute kidney injury in patients managed surgically for kidney tumours June 14, 2018

An evaluation of race, ethnicity, age, and sex-based representation in phase I to II renal cell carcinoma clinical trials in the United States June 13, 2018

Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis June 13, 2018

The association of renal cell carcinoma with gastrointestinal stromal tumors June 12, 2018

Basic Parameters of Blood Count, Serum Sodium, and Creatinine as Prognostic Factors for Renal Cell Carcinoma at Five-Year Follow-Up June 11, 2018

An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors June 11, 2018

Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: A study of the Getug group June 7, 2018

Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum June 6, 2018

A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model June 6, 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma June 5, 2018

Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies June 4, 2018

Validation of the 16-Gene Recurrence Score in patients with locoregional, high-risk renal cell carcinoma from a phase 3 trial of adjuvant sunitinib June 4, 2018

Page 222 of 457